Boston Scientific

Latest Headlines

Latest Headlines

Boston Scientific ordered to pay up for pacemaker replacement surgery by EU court

Boston Scientific advised physicians about a particular pacemaker in 2005--but then declined to pay the bills for those surgeries that it subsequently received from German health insurers. An EU court ruled on March 5 that the company is liable for those costs, according to Reuters.

Boston Sci to acquire Endo's men's health devices for $1.6B

During the continued wave of life science M&A, companies are seeking to focus on core competencies. Once again, this trend has resulted in Boston Scientific snatching the medical device assets of a pharma company, this time from Endo International.

Boston Scientific launches upgraded endoscope, says it will reduce repeat procedures

Boston Scientific touted its new cleared endoscopic SpyGlass DS Direct Visualization System enabling direct visualization of the biliary tree and pancreatic ducts. With the FDA's 510(k) clearance now in hand, the device can hit the market.

Reuters: Boston Scientific close to $2B deal for Endo's AMS device unit

Boston Scientific sat out most rounds of med tech M&A the past few years, but the device giant might be charting a different course in 2015. The company is reportedly close to buying Endo International's AMS medical device unit in a deal estimated at $2 billion.

KKR-backed Panasonic Healthcare to buy Bayer diabetes device biz for as much as $2.3B

Bayer is slated to sell its diabetes devices business to Panasonic Healthcare, according to a report from Bloomberg. The move has been years in the making as Bayer works to sell off peripheral businesses to focus on its core profitable ones.

Boston Scientific hands over $600M to settle breach-of-contract Guidant suit with J&J

Boston Scientific is forking over $600 million to settle its ongoing breach-of-contract lawsuit with Johnson & Johnson over a failed bidding war for devicemaker Guidant, laying its decade-old courtroom saga to rest.

Boston Scientific partners with Bard to distribute Lutonix drug-coated angioplasty balloon in the U.S.

The market for drug-coated angioplasty balloons to treat peripheral artery disease has been bursting with activity in recent months. Boston Scientific joined the parade today, albeit as a distributor. 

Judge: Come to an agreement over transvaginal mesh in two days, or else the barrage of lawsuits will commence

U.S. District Judge Joseph Goodwin once again pled for a comprehensive settlement between 7 devicemakers and the plaintiffs in the 70,000 lawsuits they face over potentially dangerous transvaginal mesh.

Boston Scientific CEO touts pipeline during earnings call

Shares of Boston Scientific are up slightly on earnings of $87 million on revenues of $1.9 billion in the fourth quarter of 2014, representing a change of 3% year over year.

Boston Scientific takes on Medtronic, launches upgraded implantable defibrillators with longer battery life

Industry players are scrambling to differentiate their implantable cardioverter defibrillators that deliver electric shocks to correct abnormal heart rhythms in patients with ventricular tachycardia or fibrillation. Medtronic has touted studies showing that its devices produce fewer unnecessary shocks than the industry norm and are easy to program. Today, it's Boston Scientific's turn.